Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t ... view more

RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.Schizophrenia is a chronic, severe,...

$ 2000


DelveInsight’s Schizophrenia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Schizophrenia for the seven major markets i.e. United States, EU5 (France, Germany, Ita...

$ 4950


DelveInsight’s Report, “Schizophrenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe...

$ 2000


Schizophrenia is a severe mental disorder that affects an individual's behaviors, thoughts, and emotions; it is extremely heterogeneous, and no two affected individuals will have the same experience. The disorder is characterized by the presence o...

$ 3995


DelveInsight “Schizophrenia - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Schizophrenia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and f...

$ 2750


Notes: Production, means the output of Schizophrenia Drug Revenue, means the sales value of Schizophrenia Drug This report studies Schizophrenia Drug in Global market, especially in North America, Europe, China, Japan, So...

$ 3500


GlobalData's clinical trial report, "Schizophrenia Global Clinical Trials Review, H2, 2016" provides an overview of Schizophrenia clinical trials scenario. This report provides top line data relating to the clinical trials on Schizophrenia. Report...

$ 2500


Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016 Summary GlobalData''s clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials ...

$ 2500


Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape. The report provid...

$ 2000


Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.The report provides comprehensive information on the therapeutics under development for...

$ 2000


This is a professional and in-depth study on the current state of the Schizophrenia Drug industry. The report provides a basic overview of the industry including defini...

$ 3600


Note*: This report requires 5-10 business days to complete. DelveInsight’s Schizophrenia - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of ...

$ 4950


Schizophrenia is a severe mental disorder that is characterized by abnormal social behavior and failure to recognize what is real; its symptoms are broadly divided into positive, negative and cognitive. The treatment of schizophrenia is multi-fact...

$ 6995


This is a professional and in-depth study on the current state of the Schizophrenia Drug industry. The report provides a basic overview of the industry includin...

$ 3800


This is a professional and in-depth study on the current state of the Schizophrenia Drug market. First, the report provides a basic overview of the Schizophrenia Dru...

$ 4000


This is a professional and in-depth study on the current state of the Schizophrenia Drug industry. Firstly, the report provides a basic overview of the industry includ...

$ 2800


Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape....

$ 2000


Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H2 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development...

$ 2000


Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)’s therapeutic pipeline. This report p...

$ 2000


This is a professional and in-depth study on the current state of the Schizophrenia Drug industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Sc...

$ 2800

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: